Two Years Ago Today the LTA was Passed by Congress!
Two years ago today, I sat glued to my computer as I watched the live stream of that day’s Congressional proceedings. Nearly 13 years after the Lymphedema Treatment Act was
Two years ago today, I sat glued to my computer as I watched the live stream of that day’s Congressional proceedings. Nearly 13 years after the Lymphedema Treatment Act was
This month, we were thrilled to have our work recognized by the Home Medical Equipment (HME) industry in the article HME’s Road Ahead. HME industry leaders cited CMS implementation of
As a reminder, the Local Coverage Determination (LCD L33829) for Pneumatic Compression Devices (PCDs) was retired on November 14, 2024. Some additional insights on this are below. If you are
Together, We’ve Made History — And the Work Continues! Thanks to your support, the Lymphedema Treatment Act became law, providing life-changing coverage for compression garments to millions. But there’s still more
On November 18th, nine organizations, including ours, the Lymphedema Advocacy Group, participated in the National Commission for Lymphatic Disease’s first ever Town Hall. A recording of this seminal event is
We are thrilled to share our new website, LymphedemaAdvocacyGroup.org! This new site will support our ongoing work to improve insurance coverage for lymphedema treatment and will continue to be developed
We invite you to attend the first ever National Commission for Lymphatic Disease (NCLD) virtual Town Hall taking place on Monday, November 18th, from 9:00am to 12:00pm Eastern time. The
We are happy to announce that the Centers for Medicare & Medicaid Services (CMS) has retired the Local Coverage Determination (LCD L33829) for Pneumatic Compression Devices (PCDs) effective today, November
Last year, the Lymphology Association of North America and the American Cancer Society hosted a lymphedema summit. The event brought together key experts and stakeholders from across North America to
Join our email list to learn about
changes to insurance coverage, advocacy actions,
new educational materials and more.
Subscribers receive approximately
one email per week with information
from both of our organizations.

